Boston Scientific Galway site

GALWAY, IRELAND (14 April 2022) - Boston Scientific Corporation (NYSE: BSX) - a global leader in medical device technology – today will unveil a new €100 million expansion of its operations at Ballybrit in Galway. The expansion is expected to enable 300+ jobs in the coming years and includes over 40,000 square feet of medical device manufacturing space that will be powered by renewable energy. 
 
“This is a welcome investment in the medical technology industry in Galway and the entire region, and it reflects real confidence in the quality and talent of the Irish workforce,” said Taoiseach Micheál Martin. “Ireland has established itself as a global leader in the sector, with exciting opportunities to produce innovations that improve patient health and quality of life.” 
 
Boston Scientific has had a strong presence in Galway for nearly 30 years and has expanded site capabilities to include advanced product design, R&D and manufacturing.  More than four million medical devices are exported from the Galway facility every year, including heart stents and valves, vascular balloons and oesophageal stents. These products help treat patients with conditions including heart disease, vascular disease, oesophageal cancer, and those at risk of stroke. The expanded site will include a carbon neutral manufacturing space in alignment with the company’s goal to achieve carbon neutrality in all manufacturing and key distribution sites by 2030.
 
“This expansion reflects the important contributions of our workforce here in Galway and the strength of the broader business and local community in the west region,” said James Lyons, vice president of Operations at Boston Scientific. “In addition to the investment in our physical space, we remain committed to fostering an inclusive workplace where all employees can find opportunities to grow in their careers.”
 
As the company continues to support new ways of working, many employees at the Galway campus have transitioned to hybrid work models, with schedules that allow for both working remotely and in the office each week. New amenities include a gym and meeting spaces that are designed to support employee well-being and on-site collaboration. 
 

 “Boston Scientific has a workforce of more than 6,500 people across its sites in Galway, Clonmel and Cork, making it the largest life sciences employer in Ireland,” said Martin Shanahan, CEO, IDA Ireland. “Today, Ireland has the highest per capita number of people employed in the European medical device industry. Boston Scientific is one of the leading global MedTech companies choosing to grow in Ireland and contribute to a vibrant industry sector, which has a key role to play in tackling the world’s biggest healthcare challenges.”